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Abstract: The tetrahydroisoquinoline (THIQ) ring system is
present in a large variety of structurally diverse natural
products exhibiting a wide range of biological activities. Routes
to mimic the biosynthetic pathways to such alkaloids, by
building cascade reactions in vitro, represents a successful
strategy and can offer better stereoselectivities than traditional
synthetic methods. S-Adenosylmethionine (SAM)-dependent
methyltransferases are crucial in the biosynthesis and diversi-
fication of THIQs; however, their application is often limited in
vitro by the high cost of SAM and low substrate scope. In this
study, we describe the use of methyltransferases in vitro in
multi-enzyme cascades, including for the generation of SAM in
situ. Up to seven enzymes were used for the regioselective
diversification of natural and non-natural THIQs on an
enzymatic preparative scale. Regioselectivites of the methyl-
transferases were dependent on the group at C-1 and presence
of fluorine in the THIQs. An interesting dual activity was also
discovered for the catechol methyltransferases used, which
were found to be able to regioselectively methylate two
different catechols in a single molecule.
Introduction
THIQs are an important group of bioactive alkaloids.
Alongside their applications as analgesics and antitussives,[1–4]
THIQs show promise as therapeutics towards cancer, neuro-
pathologies and multi-drug resistant bacteria.[3,5–8] However,
supply of these compounds for studies and clinical use is
limited. Natural THIQs can be harvested from mixtures from
certain plants, but their chemical syntheses are complicated
by the presence of chiral centres and the density of functional
groups.[9] An enzyme of particular interest has been norco-
claurine synthase (NCS), which catalyses a Pictet–Spengler
(PS) reaction between dopamine and 4-hydroxyphenylace-
taldehdye, to initiate benzylisoquinoline alkaloid (BIA)
biosynthesis. Most usefully, using natural and engineered
NCS variants,[10–12] the b-arylethylamine and carbonyl sub-
strates can be varied to generate a number of natural and non-
natural THIQs.[13–16] The diversity of THIQs generated has
been further extended by forming in vitro cascades with
enzymes upstream of NCS.[17] In plant BIA biosynthesis,
methyltransferase (MT) enzymes operate downstream of
NCS to methylate norcoclaurine.[18] Such natural product
methylations involve transfer of a methyl group from S-
adenosylmethionine (SAM) to specific nucleophilic sites on
the scaffold, and is widely associated with activation of the
compound or improvement of its biological properties.[19–24]
MTs are therefore an essential addition for the diversifi-
cation of THIQs. However, while the O-MTs involved in
producing natural BIAs are regioselective,[25, 26] they lack the
substrate scope in vivo needed to be components of a flexible
enzyme cascade to larger sets of THIQs. While in vitro
biocatalytic cascades take inspiration directly from natural
biosynthetic pathways, they allow more flexibility over
reaction design, offering control in the order and quantity
of enzymes added to the cascade as well as the enzyme used.
Importantly, the in vitro approach reduces background
reactions such as the phosphate catalysed PS,[27] and can
simplify product isolation and purification. Here we present
the use of three O-MTs in vitro, catechol-O-MTs from Rattus
norvegicus (RnCOMT),[28] Coptis japonica (Cj-6-OMT),[25,29]
and Myxococcus xanthus (MxSafC),[30] and an N-MT from
Coptis japonica (CjCNMT),[31] to establish potential reactiv-
ities towards a range of THIQs. We report the integration of
these enzymes into up to 7-step cascades for the strategic
diversification of bioactive compounds (Figure 1). The cost of
SAM has also previously limited the scale of MT-catalysed
reactions, but this challenge is resolved with the incorporation
of a reported modular in vitro cofactor supply system,[32]
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In the initial screening, a variety of THIQs were prepared
using Thalictrum flavum NCS (TfNCS), in high enantiomeric
excesses (ees) where the single isomer is indicated, and
purified.[11,16, 17] The substrate panel (Figure 2a) included
BIAs (1–5) and C-1 substituted THIQs with linear aliphatic
or cyclic moieties (6–11). BIAs lacking the catechol group on
the isoquinoline scaffolds or those bearing a halide group (12–
14) were also included. All substrates 1–14 were tested with
MTenzymes RnCOMTand MxSafC. Cj-6-OMTwas also used
for comparison as it is known to selectively methylate in vivo
the 6-OH of norcoclaurine (S)-2.[29] Initially, purified enzymes
were used for reactions with substrates 1–3. With the aim of
scaling up the process and making it more viable in an
industrial setting, the same reactions were also carried out
with clarified lysates, showing regioselectivities that were
comparable to the purified O-MTs (SI section 3.2). Clarified
lysates were then used with all the substrates. We were
delighted to see that all THIQs bearing a catechol were
readily accepted and new peaks were detected by HPLC
Figure 1. (a) Formation of THIQs using enzymes and O- or N-methyl-
ation using methyltransferases (MTs) and an S-adenosylmethionine
(SAM) supply/S-adenosylhomocysteine (SAH) degradation system;
(b) The route to biologically relevant methylated THIQs prepared in
this work via cascades with up to 7-enzymes. Abbreviations: E. coli
(Ec); methionine adenosyltransferase (MAT); methylthioadenosine
nucleosidase (MTAN); L-methionine (L-Met); adenosine triphosphate
(ATP); S-ribosyl-L-homocysteine (SRH).
Figure 2. Substrates used with the selected MTs indicated. (a) Structures of the THIQs tested. (b) Reaction conversions are based on the
consumption of the THIQ analogues 1–14 used, by HPLC analysis against standard calibration curves. Reaction conditions: THIQ 0.5 mM, SAM
3 mM, and selected MTs (clarified lysate, 10% v/v) which showed conversions after 90 min: RnCOMT in blue, MxSafC in purple, and Cj-6-OMT in
pink. THIQs (R,S)-12, (S)-13, and (S)-14 were not accepted by any of the MTs tested and are not reported. All reactions were performed in
duplicate. See SI for representative HPLC chromatograms and calibration curves.
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within the first hour (Figure 2b and SI Figure S5). In general,
RnCOMT and MxSafC showed broader substrate scope
relative to Cj-6-OMT, with excellent activities towards
THIQs with an aliphatic side chain (6–10), which were only
slightly or not converted by Cj-6-OMTunder these conditions.
Notably, complete conversions were obtained within the first
90 min with substrates 1–11 with RnCOMT, while MxSafC
showed some starting material left only in the case of
substrates 9–11. As expected, none of the THIQs lacking
a catechol moiety (12 and 14) were accepted by the MTs,
including derivative 13 where a catecholic hydroxyl group was
replaced with a bromine.
Building the Enzyme Cascades and O-MT Regioselectivities
Establishment of the regiochemistries was also key, which
required scale-up of the reactions for product character-
isation. Several factors were considered. Firstly, the high cost
of the cofactor SAM restricts its use in larger scale biocat-
alytic reactions in vitro: although it has been reported in the
N-methylation of THIQs,[31] this is not practicable for wider
applications. In previous work, integration of MTs into
a linear cascade with two further enzymes overcame this
issue using a methionine adenosyltransferase (MAT
E.C. 2.5.1.6) and a methylthioadenosine nucleosidase
(MTAN, E.C. 3.2.2.9).[33] MATs generate SAM from ATP
and L-methionine, both of which are less expensive and
importantly more stable than SAM. When SAM is used for
the methylation reaction, S-adenosylhomocysteine (SAH) is
formed as a by-product. SAH, which would otherwise inhibit
the methylation, can then be cleaved by the MTAN into S-
ribosyl-L-homocysteine (SRH) and adenine (Figure 1a). For
the SAM supply/SAH degradation system, enzymes MATand
MTAN, both from E. coli (EcMAT and EcMTAN, respec-
tively) were selected.[33] Secondly, clarified lysates were used
instead of pure enzymes to avoid
the requirement for enzyme purifi-
cation steps. Thirdly, to further
streamline the process, the methyl-
ation cascade reaction was coupled
directly to the NCS-catalysed PS
reaction in a one-pot, two-step
cascade, obviating the need for
purification of the THIQ inter-
mediates. The methylation of rep-
resentative substrates (S)-1, (S)-6,
9, 10 and (S)-11 was explored first
(Scheme 1. ees for (S)-1 (> 97%)
and (S)-6 (> 98%) are shown in
the SI). Here it was essential that
all the dopamine was consumed in
the TfNCS catalysed reaction be-
fore the MT step to avoid the
methylation of unreacted dopa-
mine,[33] which could interfere with
the regiochemical outcome.
With the architecture of the
cascades defined, a biocatalytic
scale-up of the methylated THIQs was attempted in a single
pot. Starting from dopamine (5–20 mM) and an excess of the
corresponding carbonyl compound, the THIQs (S)-1, (S)-6,
9,10 and (S)-11 were generated with high enantiopurity (for
single isomer compounds) and the methylation step initiated
by the addition of RnCOMT clarified lysate (10 % v/v) in the
presence of ATP, L-methionine and the SAM supply/SAH
degradation system enzymes EcMAT (10 % v/v) and EcM-
TAN (2.5% v/v). Using RnCOMT the methylated products
(S)-6-OMe-1, (S)-6-OMe-6, 7-OMe-9, 7-OMe-10, and (S)-6-
OMe-11 were isolated with good yields and high regioselec-
tivities with only 5–10 % of the opposite regioisomer detected
by 1H NMR spectroscopy in most cases (Table 1). As
expected, the regiochemistry of the reaction was strongly
dependent on the nature of the side chain, which directed the
Scheme 1. Four-enzyme cascades for the synthesis of: (a) THIQs (S)-
6-OMe-1, (S)-6-OMe-6, and (S)-6-OMe-11, and (b) THIQs 6-OMe-9, 7-
OMe-9, 6-OMe-10, and 7-OMe-10 from 9 and 10 respectively.
Table 1: Isolated yields and regioisomeric ratios for the preparative scale cascade reactions described in
Schemes 1–3.
Substrate Product MT Yield[a] Regioisomeric ratio[b]
(6-OMe:7-OMe)
(S)-1 (S)-6-OMe-1 RnCOMT 55 % (96%) 95:5
(S)-2 (S)-6-OMe-2 RnCOMT 55 % (92%) 95:5
(S)-2 (S)-6-OMe-2 MxSafC[c] 43 % (89%) 60:40
(S)-2 (S)-6,7-(OMe)2-2 MxSafC
[c] 6% (9%)[d] na
(S)-3 (S)-6,3’-(OMe)2-3 RnCOMT 34% (64%)
[e] 95:5
(S)-3 (S)-6,4’-(OMe)2-3 Cj-6-OMT then MxSafC 27% (70%)
[e] 100
(S)-5 (S)-6-OMe-5 RnCOMT 19 % (27%) 95:5
(S)-5 (S)-6-OMe-5 MxSafC 20 % (31%) 95:5
(S)-6 (S)-6-OMe-6 RnCOMT 44 % (90%) 90:10
9 7-OMe-9 RnCOMT 40% 10:90
9 6-OMe-9 MxSafC 56% (94%)[f ] 90:10
10 7-OMe-10 RnCOMT 45%[g] (90%) 10:90
10 6-OMe-10 MxSafC 30%[g] (89%) 90:10
(S)-11 (S)-6-OMe-11 RnCOMT 33 % (40%) 85:15
[a] Isolated yield (yield by HPLC analysis against product standards in parenthesis); [b] 6-OMe:7-OMe
calculated by NMR; [c] reaction with 2 equivalents of ATP and L-methionine; when an excess of methyl
equivalents was used the dimethylated product (S)-6,7-(OMe)2-2 was observed; [d] the yield of (S)-6,7-
(OMe)2-2 with 8 equiv of ATP and L-methionine was 28% (47%); [e] some impurities were detected by
HPLC; [f ] reaction on a pure sample of 9. When carried out in a cascade coupled with NCS the yield was
64% (not optimised); [g] reaction on a pure sample of 10.
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methylation preferentially at the 6-OH for substrates (S)-1,
(S)-6, and (S)-11, and surprisingly preferably on the 7-OH for
substrates 9 and 10. Interestingly, when 9 or 10 underwent the
same reaction conditions with MxSafC, the 6-OH was
methylated instead preferentially and derivatives 6-OMe-9
or 6-OMe-10 respectively were obtained in good yield and
excellent regioselectivities (Table 1). This unique perfor-
mance with a switch in the regioselectivities for both
RnCOMT and MxSafC further confirms the complementarity
of these two enzymes.[33]
With the challenge to demonstrate the potential of this
approach, the methylation with RnCOMT was further cou-
pled with a multistep in vitro enzyme cascade for the in situ
generation of norcoclaurine (S)-2 (generated in > 97% ee)
using Candidatus Nitrosopumilus salaria BD31 tyrosinase
(CnTYR) and Enterococcus faecalis DC32 tyrosine decar-
boxylase (EfTyrDC), together with a versatile transaminase
from Chromobacterium violaceum[34] (CvTAm) and wild-type
TfNCS enzyme.[17] A total of seven enzymes as clarified cell-
lysates were used in the same pot, achieving the conversion of
L-tyrosine into (S)-coclaurine (S)-6-OMe-2 in an unique one-
pot three step cascade (Scheme 2a).
The methylation with RnCOMT was almost completely
regioselective with no appreciable regioisomeric peak de-
tected by HPLC. When the cascade was scaled up to 50 mL
(L-tyrosine 20 mM), (S)-6-OMe-2 was isolated in 55 % yield
and small amounts (5 % of total product) of the 7-O-
methylated regioisomer were detected by 1H NMR spectros-
copy. The lower isolated yields compared to the complete
conversion of the starting material and the almost quantita-
tive yield measured by HPLC, reflects again the challenge of
purifying such alkaloids.[35] Catechol O-MTs such as
RnCOMT have not been shown to methylate adjacent
hydroxy groups or phenols, even in the presence of an excess
of methyl equivalents. Interestingly, the structurally related
MxSafC, proved to be an exception. This consideration
derives from the fact that methylation of (S)-2 with MxSafC
and an excess of SAM, led to a regioisomeric mixture of (S)-6-
OMe-2 and (S)-7-OMe-2 (ratio 60:40), which were converted
over time into a third product. This unexpected product was
isolated and characterized confirming the structure of the 6,7-
dimethoxy tetrahydroisoquinoline (S)-6,7-(OMe)2-2 (see the
SI).
A one-pot cascade was also established for the synthesis
and methylation of (S)-5 (formed in 90 % ee) (Scheme 2b).
CnTYR and EfTyrDC were used for the hydroxylation and
decarboxylation of 3-F-L-tyrosine,[17] then reaction with
phenylacetaldehyde and TfNCS followed by methylation
with RnCOMT on the crude reaction mixture, gave the 6-O-
methylated derivative (S)-6-OMe-5 which was isolated in
19% yield (27 % HPLC yield) over the 7-enzyme steps.
Similarly, using MxSafC gave (S)-6-OMe-5 in 20% yield
(31 % HPLC yield). The limiting step is most likely the initial
hydroxylation with CnTYR. The preferential methylation at
the 6-OH position by both MTs is likely a consequence of
substrate-active site interactions. However, the change in
MxSafC regioselectivity between (S)-1 and fluorinated (S)-5
indicates electronic factors are also important. The fluorine
adjacent to a catechol moiety decreases the pKa of the
neighbouring -OH and has previously been shown to direct
the methylation on the hydroxyl group to a position equiv-
alent to that at 7-OH.[36] Here, the fluorine at C-8 in the THIQ
scaffold directs the methylation unexpectedly towards (S)-6-
OMe-5 with MxSafC. Notably, MxSafC led to a mixture of the
two regioisomeric products when (S)-1, lacking the fluorine,
was used as starting material. We hypothesized that a subtle
substrate conformational change together with an intramo-
lecular hydrogen bonding between the fluorine and the
adjacent -OH, can make methylation at that position more
difficult.
Extending the Enzyme Cascades for Further O- and N-
methylations
A case of particular interest is norlaudanosoline (S)-3.
This is a substrate for Cj-6-OMT and it is converted to the
corresponding 6-O-methylated derivative (S)-6-OMe-3.[29]
When the assay was performed with either RnCOMT or
MxSafC and an excess of SAM, new product peaks not
attributable to the 6- or 7-O-methylated products were
identified by HPLC. Interestingly, when only one equivalent
of SAM was used with RnCOMT, the peak corresponding to
6-O-methylated 3 was identified as the main product together
with some starting material. If MxSafC was used instead,
a mixture of two regioisomeric methylated products was
identified (SI Figure S5). With the aim of elucidating the
structure of the new products, a two-step, five-enzyme
cascade was established for the synthesis and methylation of
norlaudanosoline (S)-3 (formed in > 97 % ee) in one pot
(Scheme 3) starting from dopamine (20 mM). The wild-type
TfNCS enzyme and CvTAm[34] were used in the first step,[37]
Scheme 2. (a) Seven-enzyme cascades for the synthesis of THIQs (S)-
6-OMe-2, (S)-7-OMe-2 and (S)-6,7-(OMe)2-2 and (b) six-enzyme cas-
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and the methylation step was then coupled and scaled up
using RnCOMT together with the SAM supply/SAH degra-
dation system. Product isolation confirmed that a second
methylation occurred on the catechol moiety of the C-1 side
chain and RnCOMT proved to be exceptionally selective,
with methylation preferentially occurring at the 6-OH and the
3’-OH. Complete conversion into nororientaline (S)-6,3’-
(OMe)2-3 was observed, which was isolated in 33% yield.
This double methylation is completely unprecedented as it is
known to be carried out by two different MTs in the BIA
biosynthetic pathway, with RnCOMT combining the activity
of a 6-OMT and a 3’-OMT.[38] MxSafC showed a similar
performance, leading to a mixture of 6-OMe and 7-OMe-(S)-
norlaudanosoline which were then converted into the corre-
sponding dimethylated analogues (S)-norreticuline (S)-6,4’-
(OMe)2-3 and (S)-norprotosinomenine
[39] (S)-7,4’-(OMe)2-3
in the presence of an excess of methyl equivalents.[*]
Although less selective, MxSafC could also combine the
activity of two methyltransferases, including a 4’-OMT. This
reactivity was used for the selective synthesis of (S)-norreticu-
line (S)-6,4’-(OMe)2-3 by coupling the Cj-6-OMT and the
MxSafC in a one-pot three-step cascade (Scheme 3), high-
lighting the ability to mix and match MTs to directed
products.
Finally, N-methylation of (S)-6-OMe-1 and (S)-6,3’-
(OMe)2-3 (S)-nororientaline was also investigated for the
total synthesis of (S)-2-NMe-6-OMe-1 and orientaline (S)-2-
NMe-6,3’-(OMe)2-3 respectively (Scheme 4). CjCNMT is
known to methylate coclaurine and several natural THIQs,
including norlaudanosoline.[31, 40, 41] In a first attempt to
synthesize the desired products, the N-methylation step was
carried out in the same pot (in a cascade starting from
dopamine), after completion of the RnCOMT step, by the
addition of purified CjCNMT (methylation steps shown in
Scheme 4). (S)-6,3’-(OMe)2-3 was converted in 16 hours and
(S)-orientaline (S)-2-NMe-6,3’-(OMe)2-3 was isolated in 38%
yield (overall from dopamine). Compound (S)-6-OMe-1 was
also accepted by CjCNMT and converted into the corre-
sponding N-methylated product (S)-2-NMe-6-OMe-1 with
a 46% isolated yield (in a cascade starting from dopamine)
and 66 % yield by HPLC analysis. Notably, this SAM-
dependent N-MT was shown to be active if coupled with the
SAM supply/SAH degradation system. To our delight, the
CjCNMT also showed comparable activity if added together
with the RnCOMT in the same step, reducing reaction times;
(S)-2-NMe-6-OMe)-1 and (S)-orientaline (S)-2-NMe-6,3’-
(OMe)2-3 were obtained in less than 48 hours in a two-step
one-pot cascade from dopamine. In both cases traces (< 5%)
of the minor isomers (S)-2-NMe-7-(OMe)-1 and (S)-2-NMe-
7,3’-(OMe)2-3, were noted.
Generally, RnCOMT is highly selective and the 6-OH is
preferentially methylated except in the case of spiro-THIQs 9
and 10, where a complete inversion of the selectivity was
observed. To understand this pattern of regioselectivity,
a selection of THIQs were docked into models of the
RnCOMT and MxSafC active sites using AutoDock Vina.[42]
The catechol-binding pocket forms a deep groove with the
magnesium ion proximal to highly conserved lysine residues
(K144 and K145 in RnCOMT and MxSafC respectively)
involved in the deprotonation of the hydroxyl to be methy-
lated. The catechol moiety coordinates with the magnesium
ion, while the side chain establishes interactions in the outer
region pointing either towards the so called „hydrophobic
wall“ or towards the solvent,[35, 43] defining the catechol
position which is preferentially methylated. Nevertheless,
none of our models could completely support the regioselec-
tivity observed, presumably due to the high degree of
reorientation of the active site around the specific sub-
strate.[30] However, some docking analysis with (S)-6-OMe-3
and RnCOMT (which exhibited high regioselectivity for the
second methylation at 3’-OH) and MxSafC (which favored
the second methylation at 4’-OH) provided useful insights
consistent with the experimental findings (SI Figure S6).
Scheme 3. Enzymes cascades for the synthesis of THIQs (S)-6,3’-
(OMe)2-3, (S)-6,4’-(OMe)2-3, and (S)-7,4’-(OMe)2-3 on a laboratory
preparative scale.
Scheme 4. Synthesis of THIQs (S)-2-NMe-6-OMe-1 and (S)-2-NMe-
6,3’-(OMe)2-3 on a laboratory preparative scale. (S)-1 and (S)-3 were
formed in cascades starting from dopamine (see Schemes 1 and 3).
[*] Due to the difficulty of isolating each component and the complexity
of the NMR data, we cannot completely rule out the presence of the
regioisomer at the 3’-OH position.
Angewandte
ChemieForschungsartikel
18825Angew. Chem. 2021, 133, 18821 – 18827 T 2021 The Authors. Angewandte Chemie published by Wiley-VCH GmbH www.angewandte.de
Conclusion
In summary, we have developed in vitro enzymatic
cascades for the synthesis of a wide range of methylated
natural and non-natural THIQ alkaloids, starting from
commercially available and inexpensive building blocks. The
application of an efficient SAM supply/SAH degradation
system, together with the use of clarified lysates coupled with
the NCS step, contribute to make the scale-up of the whole
process viable. Finally, methylated THIQ alkaloids in high
enantiopurities such as (S)-norreticuline, (S)-coclaurine, (S)-
nororientaline, and (S)-orientaline together with novel
THIQs are readily available in high purity from a one-pot
cascade. The methylation step showed exceptional regiose-
lectivity bearing in mind there is a degree of non-enzymatic
methylation (generally around 4%) which has also been
reported in the literature.[30, 44] An unprecedented dual activity
has also been discovered for the methyltransferases
RnCOMT and MxSafC, which were found to be able to
regioselectively methylate two different catechols in a single
molecule. This unique activity permitted the regioselective
synthesis of (S)-nororientaline in one single step from the
precursor (S)-norlaudanosoline.
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